1. Home
  2. Labeler Index
  3. Medical Products Laboratories, Inc.
  4. 10733-412
  5. Label Information: Lumicain

FDA Label for Lumicain

View Indications, Usage & Precautions

Table of Contents

    1. DOSAGE & ADMINISTRATION
    2. WARNINGS AND PRECAUTIONS
    3. PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Lumicain Product Label

The following document was submitted to the FDA by the labeler of this product Medical Products Laboratories, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Dosage & Administration



FOR TOPICAL APPLICATION ONLY

For Granulation Tissue Growth: Allow packing saturated in Lumicain to remain in nail groove for 48 hours; repeat if necessary.

If hemmorrhage is profuse, dress wound with gauze saturated with Lumicain and allow to remain for 24 hours or longer.


Warnings And Precautions



CAUTION: Federal Law restricts sale and use to physician or licensed practitioner.


Package Label.Principal Display Panel




premier lumicainTM Topical Hemostatic Solution 60cc

For Rapid Control of Minor Hemorrhage

Each Gram Contains: Aluminium Chloride............250 mg.

In an aqueous base.

Enter section text here


* Please review the disclaimer below.